These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30633427)

  • 41. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents.
    Zhou P; Liang Y; Zhang H; Jiang H; Feng K; Xu P; Wang J; Wang X; Ding K; Luo C; Liu M; Wang Y
    Eur J Med Chem; 2018 Jan; 144():817-842. PubMed ID: 29306206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
    Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C
    Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and biological evaluation of novel tubulin inhibitors as antimitotic agents using a pharmacophore binding model with tubulin.
    Kim DY; Kim KH; Kim ND; Lee KY; Han CK; Yoon JH; Moon SK; Lee SS; Seong BL
    J Med Chem; 2006 Sep; 49(19):5664-70. PubMed ID: 16970393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, and biological evaluation of a new class of benzo[b]furan derivatives as antiproliferative agents, with in silico predicted antitubulin activity.
    Lauria A; Gentile C; Mingoia F; Palumbo Piccionello A; Bartolotta R; Delisi R; Buscemi S; Martorana A
    Chem Biol Drug Des; 2018 Jan; 91(1):39-49. PubMed ID: 28639390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis and bio-evaluation of novel 2-aryl-4-(3,4,5-trimethoxy-benzoyl)-5-substituted-1,2,3-triazoles as the tubulin polymerization inhibitors.
    Huang L; Liu M; Man S; Ma D; Feng D; Sun Z; Guan Q; Zuo D; Wu Y; Zhang W; Bao K
    Eur J Med Chem; 2020 Jan; 186():111846. PubMed ID: 31740055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thymoquinone inhibits microtubule polymerization by tubulin binding and causes mitotic arrest following apoptosis in A549 cells.
    Acharya BR; Chatterjee A; Ganguli A; Bhattacharya S; Chakrabarti G
    Biochimie; 2014 Feb; 97():78-91. PubMed ID: 24113316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and biological evaluation of quinoxaline derivatives as tubulin polymerization inhibitors that elevate intracellular ROS and triggers apoptosis via mitochondrial pathway.
    Qi J; Huang J; Zhou X; Luo W; Xie J; Niu L; Yan Z; Luo Y; Men Y; Chen Y; Zhang Y; Wang J
    Chem Biol Drug Des; 2019 Apr; 93(4):617-627. PubMed ID: 30635972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of Novel Quinoline-Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity.
    Li W; Xu F; Shuai W; Sun H; Yao H; Ma C; Xu S; Yao H; Zhu Z; Yang DH; Chen ZS; Xu J
    J Med Chem; 2019 Jan; 62(2):993-1013. PubMed ID: 30525584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents.
    Jiang J; Sun B; Wang YY; Cui M; Zhang L; Cui CZ; Wang YF; Liu XG; Lou HX
    Bioorg Med Chem; 2012 Apr; 20(7):2382-91. PubMed ID: 22365913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methyl 5-[(1H-indol-3-yl)selanyl]-1H-benzoimidazol-2-ylcarbamate (M-24), a novel tubulin inhibitor, causes G2/M arrest and cell apoptosis by disrupting tubulin polymerization in human cervical and breast cancer cells.
    Zuo D; Jiang X; Han M; Shen J; Lang B; Guan Q; Bai Z; Han C; Li Z; Zhang W; Wu Y
    Toxicol In Vitro; 2017 Aug; 42():139-149. PubMed ID: 28412508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, molecular docking and biological evaluation of 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as novel potential tubulin assembling inhibitors.
    Wang YT; Cai XC; Shi TQ; Zhang YL; Wang ZC; Liu CH; Zhu HL
    Chem Biol Drug Des; 2017 Jul; 90(1):112-118. PubMed ID: 28032450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agents.
    Carta D; Bortolozzi R; Sturlese M; Salmaso V; Hamel E; Basso G; Calderan L; Quintieri L; Moro S; Viola G; Ferlin MG
    Eur J Med Chem; 2017 Feb; 127():643-660. PubMed ID: 27823884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents.
    Kamal A; Shaik AB; Rao BB; Khan I; Bharath Kumar G; Jain N
    Org Biomol Chem; 2015 Oct; 13(40):10162-78. PubMed ID: 26303171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y
    Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Light-switchable hemithioindigo-hemistilbene-containing peptides: ultrafast spectroscopy of the Z → E isomerization of the chromophore and the structural dynamics of the peptide moiety.
    Regner N; Herzog TT; Haiser K; Hoppmann C; Beyermann M; Sauermann J; Engelhard M; Cordes T; Rück-Braun K; Zinth W
    J Phys Chem B; 2012 Apr; 116(14):4181-91. PubMed ID: 22423868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Photostability of 4,4'-dihydroxythioindigo, a mimetic of indigo.
    Dittmann M; Graupner FF; Maerz B; Oesterling S; de Vivie-Riedle R; Zinth W; Engelhard M; Lüttke W
    Angew Chem Int Ed Engl; 2014 Jan; 53(2):591-4. PubMed ID: 24282071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis and biological studies of novel tubulin inhibitors.
    Sun Y; Pandit B; Chettiar SN; Etter JP; Lewis A; Johnsamuel J; Li PK
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4465-8. PubMed ID: 23790539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tools for the rational design of bivalent microtubule-targeting drugs.
    Marangon J; Christodoulou MS; Casagrande FV; Tiana G; Dalla Via L; Aliverti A; Passarella D; Cappelletti G; Ricagno S
    Biochem Biophys Res Commun; 2016 Oct; 479(1):48-53. PubMed ID: 27613098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors.
    Yin Y; Qiao F; Jiang LY; Wang SF; Sha S; Wu X; Lv PC; Zhu HL
    Bioorg Med Chem; 2014 Aug; 22(15):4285-92. PubMed ID: 24916028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of benzo[d]imidazo[2,1-b]thiazole-chalcone conjugates as microtubule targeting and apoptosis inducing agents.
    Sultana F; Reddy Bonam S; Reddy VG; Nayak VL; Akunuri R; Rani Routhu S; Alarifi A; Halmuthur MSK; Kamal A
    Bioorg Chem; 2018 Feb; 76():1-12. PubMed ID: 29102724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.